SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-20-044387
Filing Date
2020-04-08
Accepted
2020-04-08 06:01:36
Documents
2
Group Members
SANKESH ABBHI

Document Format Files

Seq Description Document Type Size
1 SC 13D a20-12881_2sc13d.htm SC 13D 98285
2 EX-1 a20-12881_2ex1.htm EX-1 7868
  Complete submission text file 0001104659-20-044387.txt   108021
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Subject) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79890 | Film No.: 20781026
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3119 PONCE DE LEON UNIT C CORAL GABLES FL 33134
Business Address 3119 PONCE DE LEON UNIT C CORAL GABLES FL 33134 (312) 207-3863
Abbhi Investments, LLC (Filed by) CIK: 0001806888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: FL
Type: SC 13D